S1129 Does Rifaximin Treatment Impact Results of Glucose and Lactulose Breath Testing in Patients With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)?
Borko Nojkov(Michigan Medicine), William D. Chey(University of Michigan–Ann Arbor), Matthew Kwok, Shanti Eswaran(Kenya Institute for Public Policy Research and Analysis), Prashant Singh(Michigan Medicine), Samuel W. Chey(Michigan Medicine), Allen Lee, Matthew B. Sturm
Cited by 0
Related Papers
Functional Bowel Disorders
|Gastroenterology|2006|4.8k
Bowel Disorders
|Gastroenterology|2016|2.8k
Global Prevalence of Celiac Disease: Systematic Review and Meta-analysis
|Clinical Gastroenterology and Hepatology|2018|1.7k
Development and Validation of the Rome IV Diagnostic Questionnaire for Adults
|Gastroenterology|2016|696
A Randomized Controlled Trial Comparing the Low FODMAP Diet vs. Modified NICE Guidelines in US Adults with IBS-D
|The American Journal of Gastroenterology|2016|376